GLYCATED HAEMOGLOBIN AS A SURROGATE MARKER FOR THE APPEARANCE AND PROGRESSION OF RETINOPATHY IN TYPE-I DIABETES MELLITUS: SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Wieczorek, A. [1 ]
Marcisz, A. [1 ]
Rys, P. [1 ]
Skrzekowska-Baran, I [2 ]
Plisko, R. [1 ]
Wladysiuk, M. [1 ]
机构：
[1] HTA Consulting, Krakow, Malopolska, Poland
[2] Novo Nordisk Inc, Warsaw, Mazowieckie, Poland
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)74990-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A403 / A403
页数：1
相关论文
共 50 条
  • [1] Glycated haemoglobin as a surrogate marker for the appearance and progression of retinopathy in type 1 diabetes mellitus: systematic review and meta-analysis
    Rys, P.
    Wieczorek, A.
    Marcisz, A.
    Skrzekowska-Baran, I.
    Malecki, M. T.
    DIABETOLOGIA, 2009, 52 : S438 - S438
  • [2] Glycated haemoglobin as a surrogate marker for the appearance and progression of retinopathy in type 2 diabetes mellitus: systematic review and meta-analysis
    Rys, P.
    Wieczorek, A.
    Marcisz, A.
    Skrzekowska-Baran, I.
    Malecki, M. T.
    DIABETOLOGIA, 2010, 53
  • [3] Glycated Haemoglobin as a Surrogate Marker for the Appearance and Progression of Retinopathy in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
    Skrzekowska-Baran, Iwona
    Rys, Przemyslaw
    Wieczorek, Aleksandra
    Marcisz, Anna
    Malecki, Maciej T.
    DIABETES, 2010, 59 : A598 - A598
  • [4] GLYCATED HEMOGLOBIN AS A SURROGATE MARKER FOR THE APPEARANCE AND PROGRESSION OF MACRO VASCULAR COMPLICATIONS IN TYPE 2 DIABETES MELLITUS: SYSTEMATIC REVIEW AND META-ANALYSIS
    Weczorek, A.
    Marcisz, A.
    Rys, P.
    Skrzekowska-Baran, I
    Plisko, R.
    Wladysiuk, M.
    VALUE IN HEALTH, 2010, 13 (07) : A286 - A286
  • [5] Glycated haemoglobin as a surrogate marker for diabetic retinopathy in type 1 diabetes mellitus: systematic review and meta-analysis of randomized, observational and cross-sectional studies
    Rys, P.
    Wieczorek, A.
    Marcisz, A.
    Skrzekowska-Baran, I.
    Malecki, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 : 9 - 10
  • [6] Glycated haemoglobin variability and risk of renal function decline in type 2 diabetes mellitus: An updated systematic review and meta-analysis
    Wang, Shihan
    Song, Shuoning
    Gao, Junxiang
    Duo, Yanbei
    Gao, Yuting
    Fu, Yong
    Dong, Yingyue
    Yuan, Tao
    Zhao, Weigang
    DIABETES OBESITY & METABOLISM, 2024, 26 (11): : 5167 - 5182
  • [7] Association between glycated haemoglobin and the risk of congestive heart failure in diabetes mellitus: systematic review and meta-analysis
    Erqou, Sebhat
    Lee, Chee-Tin Christine
    Suffoletto, Matthew
    Echouffo-Tcheugui, Justin B.
    de Boer, Rudolf A.
    van Melle, Joost P.
    Adler, Amanda I.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (02) : 185 - 193
  • [8] Association between Glycated Haemoglobin and the Risk of Congestive Heart Failure in Diabetes Mellitus-Systematic Review and Meta-Analysis
    Erqou, Sebhat
    Lee, Chee-Tin Christine
    Suffoletto, Mathew
    Echouffo-Tcheugui, Justin B.
    De Boer, Rudolf A.
    Van Melle, Joost P.
    Adler, Amanda I.
    DIABETES, 2012, 61 : A78 - A78
  • [9] Effect of telemedicine on glycated haemoglobin in people with type 2 diabetes in the MENA region: a systematic review and meta-analysis
    Almaqhawi, Abdullah
    Turkistani, Jamela Abdullah
    Albahrani, Suha
    Almulhim, Abdullah
    Alsalman, Zaenb
    Albarqi, Mohammed
    Alnaim, Abdullah
    FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2022, 24 (04): : 361 - 369
  • [10] Glycated albumin as a biomarker for diagnosis of diabetes mellitus: A systematic review and meta-analysis
    Jia-Yao Xiong
    Jun-Mei Wang
    Xiao-Lan Zhao
    Chao Yang
    Xian-Shu Jiang
    Yan-Mei Chen
    Chang-Qin Chen
    Zhi-Yong Li
    World Journal of Clinical Cases, 2021, (31) : 9520 - 9534
12345